Prosthetic valve thrombosis: A regimen of treatment with low-dose and longer-course using recombinant tissue-type plasminogen activator is a promising protocol

被引:1
|
作者
Manuel Caceres-Loriga, Fidel [1 ]
Perez-Lopez, Horacio [1 ]
Morlans-Hernandes, Karel [1 ]
机构
[1] Inst Cardiol & Cardiovasc Surg, Havana, Cuba
来源
关键词
D O I
10.1016/j.jtcvs.2008.03.070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1104 / 1105
页数:5
相关论文
共 50 条
  • [11] EFFECTIVENESS OF PROLONGED LOW-DOSE RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR REFRACTORY UNSTABLE ANGINA
    ROMEO, F
    ROSANO, GMC
    MARTUSCELLI, E
    COMITO, M
    CARDONA, N
    COLISTRA, C
    MILANO, B
    BIANCO, C
    ROSANO, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (06) : 1295 - 1299
  • [12] RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY IN PROSTHETIC MITRAL-VALVE THROMBOSIS - ASSESSMENT BY TRANSTHORACIC AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY
    LOSI, MA
    BETOCCHI, S
    BRIGUORI, C
    MANGANELLI, F
    ELIA, PP
    SPAMPINATO, N
    CHIARIELLO, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 48 (03) : 219 - 224
  • [13] A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator
    Kalcik, Macit
    Gursoy, Ozan Mustafa
    Astarcioglu, Mehmet Ali
    Ozkan, Mehmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 (05): : 478 - 481
  • [14] TREATMENT OF SUPERIOR VENA-CAVA THROMBOSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    GREENBERG, S
    KOSINSKI, R
    DANIELS, J
    CHEST, 1991, 99 (05) : 1298 - 1301
  • [15] Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device
    Schrager, Benedikt
    Grahnh, Hanno
    Wagner, Florian M.
    Bernhardt, Alexander
    Rybczynski, Meike
    Blankenberg, Stefan
    Reichenspurner, Hermann
    Barten, Markus J.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2018, 7 (08) : 766 - 770
  • [16] Recombinant tissue-type plasminogen activator treatment in an extremely low birth weight infant
    Kurimoto, Tomonori
    Shimoji, Yoshikazu
    Shimabukuro, Atsuya
    Ohshiro, Tatsuo
    CLINICAL CASE REPORTS, 2021, 9 (05):
  • [17] How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
    Guner, Ahmet
    Kalcik, Macit
    Gursoy, Mustafa Ozan
    Gunduz, Sabahattin
    Ozkan, Mehmet
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (03) : 399 - 402
  • [18] How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
    Ahmet Guner
    Macit Kalcik
    Mustafa Ozan Gursoy
    Sabahattin Gunduz
    Mehmet Ozkan
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 399 - 402
  • [19] Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Renal Artery Thrombosis After Kidney Transplantation
    Garcia, A.
    Vedula, G.
    Nowygrod, R.
    Ratner, L. E.
    Goldstein, M. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (08) : 1931 - 1933
  • [20] Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage The Intraventricular Hemorrhage Thrombolysis Trial
    Naff, Neal
    Williams, Michael A.
    Keyl, Penelope M.
    Tuhrim, Stanley
    Bullock, M. Ross
    Mayer, Stephan A.
    Coplin, William
    Narayan, Raj
    Haines, Stephen
    Cruz-Flores, Salvador
    Zuccarello, Mario
    Brock, David
    Awad, Issam
    Ziai, Wendy C.
    Marmarou, Anthony
    Rhoney, Denise
    McBee, Nichol
    Lane, Karen
    Hanley, Daniel F.
    STROKE, 2011, 42 (11) : 3009 - 3016